BRPI0411954A - nanopartìculas de derivados poli-oxietilenados e respectivo método de preparação - Google Patents

nanopartìculas de derivados poli-oxietilenados e respectivo método de preparação

Info

Publication number
BRPI0411954A
BRPI0411954A BRPI0411954-1A BRPI0411954A BRPI0411954A BR PI0411954 A BRPI0411954 A BR PI0411954A BR PI0411954 A BRPI0411954 A BR PI0411954A BR PI0411954 A BRPI0411954 A BR PI0411954A
Authority
BR
Brazil
Prior art keywords
nanoparticles
preparation
polyoxyethylene derivatives
derivatives
polyoxyethylene
Prior art date
Application number
BRPI0411954-1A
Other languages
English (en)
Inventor
Fernandez Maria Jose Alonso
Barreiro Alejandro Sanchez
Noemi Csaba
Original Assignee
Advanced In Vitro Cell Tech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced In Vitro Cell Tech filed Critical Advanced In Vitro Cell Tech
Publication of BRPI0411954A publication Critical patent/BRPI0411954A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B23—MACHINE TOOLS; METAL-WORKING NOT OTHERWISE PROVIDED FOR
    • B23K—SOLDERING OR UNSOLDERING; WELDING; CLADDING OR PLATING BY SOLDERING OR WELDING; CUTTING BY APPLYING HEAT LOCALLY, e.g. FLAME CUTTING; WORKING BY LASER BEAM
    • B23K11/00—Resistance welding; Severing by resistance heating
    • B23K11/24—Electric supply or control circuits therefor
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mechanical Engineering (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"NANOPARTìCULAS DE DERIVADOS POLI-OXIETILENADOS E RESPECTIVO MéTODO DE PREPARAçãO". A invenção se refere a nanopartículas de derivados poli-oxietilenados com tamanho menor que 1 mícron, para a administração de ingredientes farmaceuticamente e cosmeticamente ativos, compreendendo um polímero biodegradável, um copolímero de bloco derivado de polioxietileno e pelo menos um ingrediente farmaceuticamente ou cosmeticamente ativo, e a um método de obtenção das ditas nanoparticulas e das composições que as contém.
BRPI0411954-1A 2003-07-04 2004-06-17 nanopartìculas de derivados poli-oxietilenados e respectivo método de preparação BRPI0411954A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200301570A ES2232287B1 (es) 2003-07-04 2003-07-04 Nanoparticulas de derivados polioxietilenados.
PCT/ES2004/000282 WO2005002550A1 (es) 2003-07-04 2004-06-17 Nanopartículas de derivados polioxietilenados

Publications (1)

Publication Number Publication Date
BRPI0411954A true BRPI0411954A (pt) 2006-08-15

Family

ID=33560937

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0411954-1A BRPI0411954A (pt) 2003-07-04 2004-06-17 nanopartìculas de derivados poli-oxietilenados e respectivo método de preparação

Country Status (10)

Country Link
US (1) US20060153923A1 (pt)
EP (1) EP1658842A1 (pt)
JP (1) JP2007525474A (pt)
KR (1) KR20060026956A (pt)
AU (1) AU2004253308A1 (pt)
BR (1) BRPI0411954A (pt)
CA (1) CA2531111A1 (pt)
ES (1) ES2232287B1 (pt)
NO (1) NO20056241L (pt)
WO (1) WO2005002550A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2044934A1 (en) * 2007-10-01 2009-04-08 Institut National De La Sante Et De La Recherche Medicale (Inserm) Dispersion of poloxamer-protein particles, methods of manufacturing and uses thereof
WO2009052493A1 (en) * 2007-10-19 2009-04-23 Bisco, Inc. Time-controlled intraoral film former system for intraoral use
ES2358403B2 (es) * 2009-10-26 2011-12-13 Universidad De Santiago De Compostela Sistema para la administración de sustancias biológicamente activas que comprende poli-epsilón-caprolactona, poloxamina y una o varias sustancias activas.
WO2012059936A1 (en) 2010-11-03 2012-05-10 Padma Venkitachalam Devarajan Pharmaceutical compositions for colloidal drug delivery
CN102008731B (zh) * 2010-12-14 2012-06-27 上海纳米技术及应用国家工程研究中心有限公司 以嵌段共聚物为载体的氟碳化合物纳米载药制剂的制备方法
ES2385995B2 (es) * 2011-01-10 2013-05-21 Universidade De Santiago De Compostela Nanocápsulas con cubierta polimérica
BR112013028570A2 (pt) * 2011-05-09 2019-09-24 Institut Quim De Sarria nanopartículas poliméricas para administração de fármacos
KR101367365B1 (ko) * 2012-01-18 2014-02-27 고려대학교 산학협력단 생체적합성 입자 및 이의 제조방법
CN104382866B (zh) * 2014-11-12 2017-08-01 中国人民解放军第二军医大学 一种包载两种表面活性剂的抗肿瘤耐药的纳米递释系统及其制备方法
WO2021158627A1 (en) * 2020-02-03 2021-08-12 Memorial Sloan Kettering Cancer Center Compositions comprising nanoparticles and methods thereof
WO2023168387A1 (en) * 2022-03-04 2023-09-07 West Pharmaceutical Services, Inc. Systems, compositions and methods for low temperature preservation of cells, bioinks, hydrogels, and tissue engineered medicinal products (temps)

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4582865A (en) * 1984-12-06 1986-04-15 Biomatrix, Inc. Cross-linked gels of hyaluronic acid and products containing such gels
GB8601100D0 (en) * 1986-01-17 1986-02-19 Cosmas Damian Ltd Drug delivery system
FR2608988B1 (fr) * 1986-12-31 1991-01-11 Centre Nat Rech Scient Procede de preparation de systemes colloidaux dispersibles d'une substance, sous forme de nanoparticules
IT1247472B (it) * 1991-05-31 1994-12-17 Fidia Spa Processo per la preparazione di microsfere contenenti componenti biologicamente attivi.
US5543158A (en) * 1993-07-23 1996-08-06 Massachusetts Institute Of Technology Biodegradable injectable nanoparticles
US5565215A (en) * 1993-07-23 1996-10-15 Massachusettes Institute Of Technology Biodegradable injectable particles for imaging
US20010053359A1 (en) * 1994-07-26 2001-12-20 Peter Watts Drug delivery composition for the nasal administration of antiviral agents
ATE252894T1 (de) * 1995-01-05 2003-11-15 Univ Michigan Oberflächen-modifizierte nanopartikel und verfahren für ihre herstellung und verwendung
CA2214889C (en) * 1995-03-10 2005-05-24 Hans Koll Polypeptide-containing pharmaceutical forms of administration in the form of microparticles and a process for the production thereof
EP0752245B1 (en) * 1995-07-05 2002-05-22 European Community Biocompatible and biodegradable nanoparticles designed for proteinaceous drugs absorption and delivery
US7276251B2 (en) * 1997-04-01 2007-10-02 Lg Life Sciences, Ltd., Inc. Sustained-release composition of drugs encapsulated in microparticles of hyaluronic acid
FR2777193B1 (fr) * 1998-04-14 2001-06-08 Coletica Particule a groupement hydroxamique chelatante d'ions metalliques et leur utilisation en cosmetique ou en pharmacie
FR2777895A1 (fr) * 1998-04-28 1999-10-29 Debio Rech Pharma Sa Polymere sequence non-reticule,procede pour sa preparation, et ses utilisations
US20030059465A1 (en) * 1998-05-11 2003-03-27 Unger Evan C. Stabilized nanoparticle formulations of camptotheca derivatives
IN191203B (pt) * 1999-02-17 2003-10-04 Amarnath Prof Maitra
WO2000064954A1 (en) * 1999-04-22 2000-11-02 Vanderbilt University Polymeric encapsulation system promoting angiogenesis
US6743446B2 (en) * 1999-12-15 2004-06-01 The Ohio State University Research Foundation Methods for stabilizing biologically active agents encapsulated in biodegradable controlled-release polymers
US6465425B1 (en) * 2000-02-10 2002-10-15 Alkermes Controlled Therapeutics, Inc. Microencapsulation and sustained release of biologically active acid-stable or free sulfhydryl-containing proteins
EP1187602A4 (en) * 2000-04-18 2004-09-15 Peptron Inc SUSTAINABLE RELEASE INJECTABLE PHARMACEUTICAL COMPOSITION AND METHODS OF PREPARING THE SAME
WO2004098570A1 (en) * 2002-10-30 2004-11-18 Spherics, Inc. Nanoparticulate bioactive agents

Also Published As

Publication number Publication date
JP2007525474A (ja) 2007-09-06
WO2005002550A1 (es) 2005-01-13
ES2232287A1 (es) 2005-05-16
KR20060026956A (ko) 2006-03-24
AU2004253308A1 (en) 2005-01-13
EP1658842A1 (en) 2006-05-24
CA2531111A1 (en) 2005-01-13
ES2232287B1 (es) 2006-11-01
NO20056241L (no) 2005-12-29
US20060153923A1 (en) 2006-07-13

Similar Documents

Publication Publication Date Title
BR0212475A (pt) Composições farmacêuticas
NO20025621D0 (no) Farmasöytisk sammensetning med vedvarende frigjöring for parenteral administrasjon av hydrofile forbindelser
ATE334663T1 (de) Arzneimittelzusammensetzung mit verzögerter wirkstoffabgabe
ATE293995T1 (de) Pharmazeutische zusammensetzungen, die wirkstoffabsorptionsfördernde verbindungen enthalten
ATE270544T1 (de) Halbfeste arzneizubereitung enthaltend isotretinoin
ITBO20050388A1 (it) Formulazione mucoadesive utili in dispositivi medici in preparazioni farmaceutiche
AU2001296865A1 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
EA200401009A1 (ru) Предварительно желатинированный крахмал в композиции с контролируемым высвобождением
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
MXPA04007980A (es) Preparado farmaceutico de sabor enmascarado en forma de pelicula o de oblea.
CU23423B7 (es) Oxazolidinonas sustituidas y su uso en el campo de la coagulación sanguínea
BR0109162A (pt) Viscoelásticos para uso na cirurgia do ouvido médio
BRPI0411954A (pt) nanopartìculas de derivados poli-oxietilenados e respectivo método de preparação
BR0210489A (pt) Formulação farmacêutica oral, processo para preparar a mesma, uso da mesa, e método para preparar um distúrbio cardiovascular em um paciente
BR9901782A (pt) Forma para dosagem de nefazodona.
CY1107819T1 (el) Φαρμακευτικη διαμορφωση της ολανζαπινης
AR032138A1 (es) Derivados de 6-hidroxi-indazol, una composicion oftalmica, y el uso de dichos derivados para la manufactura de un medicamento para el tratamiento de glaucoma
ES2130081B1 (es) Comprimido de maleato de trimebutina con recubrimiento laminar.
SE0302570D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
TR200100896T2 (tr) İkameli propanol türevleri, imalat yöntemleri, bileşimleri içeren ilaçlar, kullanımları
BR0206960A (pt) Composição farmacêutica oral, e, uso de um polìmero de ftalato de hidroxipropilmetilcelulose
DK1653923T3 (da) Oral afleveringssystem omfattende en bivæsket skum
WO1999047172A3 (en) Oral pharmaceutical compositions to be taken without liquids, which contain inclusion complexes
WO2005107702A3 (en) Sustained release, mucoadhesive vaginal pharmaceutical compositions
IL179544A0 (en) Compositions comprising flavonoids and tocotrienols and methods thereof

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUI DADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2129 DE 25/10/2011.